Moslem Taheri Soodejani

Dr. Moslem Taheri Soodejani


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2024 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
Introduction: We analyzed the changes in the top 10 non-communicable diseases (NCDs) over the past century across the World Health Organization (WHO) regions.Materials and methods: The data were extracted from the Global Burden of Disease (GBD) studies. After we accessed this source, all NCDs were sorted according to their prevalence in 2019, and the 10 most common NCDs were selected. Then, the incidence, prevalence, and mortality rates of these 10 NCDs were compared to the rates in 2000.Results: Diabetes and kidney disease had the highest increase in incidence (49.4%) and prevalence (28%) in the Eastern Mediterranean region. Substance use disorders had a huge increase (138%) in the mortality rates among women in the Americas region. On the other hand, women in Southeast Asia experienced the greatest decrease in incidence (−19.8%), prevalence (−15.8%), and mortality rates (−66%).Conclusion: In recent years, nearly all NCDs have shown an increase, yet mortality rates have declined across all regions. Lifestyle can be a major cause of this increase, but advancements in health and medical services, such as screening and treatment, have played a crucial role in improving survival rates.

1 January 2018 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
AKAzar Dokht Khosravi
Azar Dokht Khosravi
MRMitra Roointan
Mitra Roointan
EMEffat Abbasi Montazeri
Effat Abbasi Montazeri
SASajad Aslani
Sajad Aslani
MHMohammad Hashemzadeh
Mohammad Hashemzadeh
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
Introduction: Coagulase-negative staphylococci (CoNS) are normal inhabitants of human skin and mucous membranes. However, CoNS represent one of the major nosocomial pathogens, especially in immunocompromised patients. The increasing incidence of CoNS and mainly methicillin-resistant strains underlines the need for an accurate identification of Staphylococcus isolates at the species level. Analysis of the tuf gene proved to be an accurate tool for the species identification of CoNS. The aims of this study were to identify the CoNS species by tuf gene-based polymerase chain reaction method and sequencing, and to determine the frequency of CoNS clinical isolates resistant to methicillin (MRCoNS) and other antibiotics. Methods: A total of 200 staphylococci isolates were collected from various clinical samples. Phenotyping methods were used for initial identification followed by polymerase chain reaction amplification of tuf gene with subsequent sequencing. The phylogenetic relationships among species were analyzed using the neighbor-joining method based on the partial gene sequence of tuf. Microbroth dilution test was used for screening methicillin resistance, and disk diffusion susceptibility testing was performed for evaluation of antibiotic resistance among the isolates. Results: In the present study, 125 isolates were identified as CoNS; among them, Staphylococcus epidermidis 54(43.2%) and Staphylococcus haemolyticus 50 (40.0%) were demonstrated as the most prevalent species. Resistance to methicillin was detected in 54.4% of the CoNS based on microbroth dilution method. In disk diffusion susceptibility testing, the greatest resistance of CoNS was demonstrated for cefoxitin (65.4%), cotrimethoxazole (54.4%), and clindamycin (49.6%), while daptomycin (87.2%) and linezolid (83.2%) showed the greatest effectiveness for CoNS isolates. Conclusion: Our results confirmed the predominance of S. epidermidis and S. haemolyticus among CoNS isolates. The high prevalence of MRCoNS strains is a serious concern and strongly suggests the need for control program measures in our hospitals in order to reduce MRCoNS infections, especially in immunocompromised patients.

1 November 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
STSeyyed Mohammad Tabatabaei
Seyyed Mohammad Tabatabaei
ADAli Dehghani
Ali Dehghani
WMWilli McFarland
Willi McFarland
HSHamid Sharifi
Hamid Sharifi
Background: Mass screening for the coronavirus disease 2019 (COVID-19) began in Iran on March 23, 2020, with the purpose of improving early detection of patients for their own health and to prevent onward transmission to others. In this study, we evaluated the impact of the change towards mass screening on new cases reported, cases recovered, and deaths due to COVID-19. Methods: This study analyzed the daily reports on the number of new cases confirmed by polymerase chain reaction (PCR) testing, cases recovered, and deaths due to COVID-19 provided to the Ministry of Health and Medical Education of Iran. Changes in trends on these outcomes were evaluated using interrupted time series analysis. Results: From February 19 to May 6, 2020, a total of 519544 COVID-19 tests were done and 101650 diagnoses were made (case/ test ratio 19.6%). For the same period, 6418 deaths due to COVID-19 were reported (case fatality ratio 6.3%). The number of cases detected increased significantly over the period of scale-up of mass screening (P=0.003), as did the number of recovered cases (P=0.001). The number of deaths due to COVID-19 did not change before versus after mass screening. Conclusion: Following the scale-up of mass screening for COVID-19 in Iran, the rate of new cases detected and reported recovered accelerated significantly. Mass screening is likely to have detected many mild and asymptomatic cases that were infectious. Our data support the role that mass screening, coupled with isolation and contract tracing, can have in slowing the COVID-19 epidemic.

1 January 2023 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
Introduction: This study reports the prevalence of the 5 most common cancers and their geographical distribution based on the last update of cancer statistics in Iran (2019). Materials and methods: The data used in this study were extracted from the Global Burden of Disease (GBD) studies. It was prepared regarding sex in different provinces. Moran’s I test was used to check geographical correlation and identify hot spots and cold spots. A significance level of 5% was considered in all tests. Results: The most prevalent cancers among Iranian women reported Breast (312 per 100 000; 95% UI: 281-345), Thyroid (43 per 100 000; 95% UI: 26-51), Colon and Rectum (43 per 100 000; 95% UI: 39-47), Leukemia (33 per 100 000; 95% UI: 21 -41), and Uterine (29 per 100 000; 95% UI: 14-35) respectively; further, the most prevalent cancers among Iranian men reported Prostate (219 per 100 000; 95% UI: 158-258), Colon and Rectum (80; 72-88), Bladder (65 per 100 000; 95% UI: 58-71), Leukemia (40 per 100 000; 95% UI: 20-51), and Testicular (33 per 100 000; 95% UI: 20-48) respectively. Conclusion: exclusive of any type of skin cancer, Breast, prostate, colon and rectum, bladder, thyroid, testicular, uterine, and leukemia are most prevalent cancers in Iranian population.

1 December 2019 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
AHAli Akbar Haghdoost
Ali Akbar Haghdoost
ASAbbas Sedaghat
Abbas Sedaghat
MBMohammad Reza Baneshi
Mohammad Reza Baneshi
FZFarzaneh Zolala
Farzaneh Zolala
Background: The rate of viral infections in donated bloods is one of the main indicators of blood safety which has to be monitored precisely. This paper provides a thorough study of blood safety indicators in the last 15 years in Iran. Methods: The data of the transfusion organization in Iran from years 2003 to 2017 were used. The study focuses on the analysis of the frequency of viral hepatitis B and C (HBV and HCV) as well as human immunodeficiency virus (HIV) in blood donations. Results: Of 27,442,124 donated bloods, the relative frequencies were 4, 302, and 81 for HIV, HBV and HCV, respectively. This study also shows that the corresponding frequencies were significantly lower in recent years (2.5, 53, and 26 per 100,000 samples in 2017). Conclusion: The presented study indicates an overall low infection rate and provides evidence for the effectiveness of modern safety measures in improving the level of blood safety in Iran.

25 January 2024 in Early Child Development and Care
Verified
Journal Article
Closed access
SRShahrzad Rezaee Rezvan
Shahrzad Rezaee Rezvan
MRMahdieh Rezaee Rezvan
Mahdieh Rezaee Rezvan
SZSeyedeh Nastaran Asad Zadeh
Seyedeh Nastaran Asad Zadeh
STSeyed Saeed Torabi
Seyed Saeed Torabi
MSMoslem Taheri Soodejani
Moslem Taheri Soodejani
NFNima Firouzeh
Nima Firouzeh